Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case

Alessandro Capucci1, Luca Santini2, Stefano Favale3

  • 1Clinica di Cardiologia e Aritmologia, Università Politecnica delle Marche, "Ospedali Riuniti", Via Conca, 71, 60020, Ancona, Italy.

ESC Heart Failure
|January 12, 2019
PubMed

Insights

The HeartLogic algorithm, using implantable cardioverter defibrillator (ICD) sensors, effectively predicts heart failure (HF) decompensation. This remote monitoring tool shows promise in managing HF patients and preventing hospitalizations.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Heart failure (HF) management relies on timely detection of decompensation.
  • Remote monitoring of HF patients is crucial for proactive care.
  • Implantable cardioverter defibrillator (ICD) devices offer potential for integrated HF monitoring.

Purpose of the Study:

  • To evaluate the clinical utility of the HeartLogic algorithm for remote HF monitoring.
  • To assess the HeartLogic index's ability to predict HF decompensation events.
  • To describe real-world post-implantation data of HeartLogic in HF patients.

Main Methods:

  • Retrospective analysis of data from 58 patients with ICDs and cardiac resynchronization therapy (CRT-ICD).
  • Activation of the HeartLogic feature on a remote monitoring platform.
  • Analysis of sensor data (heart rate, sounds, impedance, respiration, activity) and the HeartLogic index against clinical events.

Main Results:

  • HeartLogic alerts preceded 5 HF hospitalizations and 5 unplanned HF visits in 16 patients over 24 person-years.
  • Alerts provided a median early warning time, longer for hospitalizations than minor deteriorations.
  • Changes in heart sound amplitude were detected in all alert cases.

Conclusions:

  • The HeartLogic algorithm demonstrates potential for detecting gradual HF worsening.
  • This tool may aid in stratifying the risk of HF decompensation.
  • Real-world clinical data supports HeartLogic's utility in HF patient management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
907
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
877
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
332
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
308